Prognosis of esophageal squamous cell carcinoma: Analysis of clinicopathological and biological factors

American Journal of Gastroenterology

Volumn 94, Issue 7, 1999, Pages 1933-1940

  Wang, Liang Shun ^a   Chow, Kuan Chih ^c   Chi, Kwan Hwa ^a   Liu, Chia Chuan ^a   Li, Wing Yin ^a   Chiu, Jen Hwey ^b   Huang, Min Hsiung ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; SURVIVAL RATE;

EID: 0033015159     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01233.x     Document Type: Article

References (60)

1. Wu Y.K., Chen P.T., Fang J., et al. Surgical treatment of esophageal carcinoma. Am J Surg. 139:1980;805-809.
2. Wang L.S., Huang M.H., Huang B.S., et al. Gastric substitution for resectable carcinoma of the esophagus. An analysis of 368 cases. Ann Thorac Surg. 53:1992;289-294.
3. Wang L.S., Chi K.H., Hu M.H., et al. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. J Surg Oncol. 62:1996;22-29.
4. Oka M., Yamamoto K., Takahashi M., et al. Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal carcinoma. Cancer Res. 56:1996;2776-2780.
5. Patil P., Redkar A., Patel S.G., et al. Prognosis of operable squmaous cell carcinoma of the esophagus. Cancer. 72:1993;20-24.
6. Sarbia M., Bittinger F., Porschen R., et al. Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res. 16:1996;2117-2122.
7. Tanigawa N., Matsumura M., Amaya H., et al. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 79:1997;220-225.
8. Doki Y., Shiozaki H., Takara H., et al. Prognostic value of DNA ploidy in squamous cell carcinoma of esophagus analyzed with improved flow cytometric measurement. Cancer. 72:1993;1813-1818.
9. Ozawa S., Ueda M., Adno N., et al. Prognostic significance of epidermal growth factor receptor in esophageal squmaous cell carcinoma. Cancer. 63:1989;2169-2173.
10. Iihara K., Shiozaki H., Takara H., et al. Prognostic significance of transforming growth factor-α in human esophageal carcinoma. Cancer. 71:1993;2902-2909.
11. Hickey K., Grehan D., Reid I.M., et al. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer. 74:1994;1693-1698.
12. Maesawa C., Tamura G., Suzuki Y., et al. Aberrations of tumor-suppressor genes (p53, apc, mcc & Rb) in esophageal squamous-cell carcinoma. Int J Cancer. 57:1994;21-25.
13. Wang D.Y., Xing Y.Y., Tanaka M., et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer. 74:1994;3089-3096.
14. Ikeda Y., Ozawa S., Ando N., et al. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinoma. Ann Thorac Surg. 62:1996;835-838.
15. Tsuda T., Tahara E., Kajiyama G., et al. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res. 49:1989;5505-5508.
16. Tamura S., Shizaki H., Miyata M., et al. Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus. Br J Surgery. 83:1996;1608-1614.
17. Ohbu M., Saegusa M., Kobayashi N., et al. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer. 79:1997;1287-1293.
18. Yoshida Y., Okamura T., Yano K., et al. Silver stained nucleolar organizer region proteins and helix pomatia agglutinin immunostaining in esophageal carcinoma: Correlated prognostic factors. J Surg Oncol. 56:1994;116-121.
19. Liu C.C., Fahn H.J., Wu Y.C., et al. Lymph node metastasis in squamous cell carcinoma of the intrathoracic esophagus. Chin Med J(Taipei). 61:1998;77-84.
20. Chiu J.H., Kao H.L., Wu L.H., et al. Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry. J Clin Invest. 89:1992;539-545.
21. Wang L.S., Wu L.H., Chang C.J., et al. Flow-cytometric DNA content analysis of oesophageal carcinoma - Comparison between tumour and sequential non-tumour mucosae. Scand Cardiovasc J. 32:1998;205-212.
22. Chiu C.F., Chow K.C., Lin F.M., et al. Expression of DNA topoisomerase IIa and multidrug resistance p-glycoprotein in acute leukemia. Chin Med J (Taipei). 60:1997;184-190.
23. Schneider P.M., Huang M.C., Chiocca S.M., et al. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res. 49:1989;4968-4971.
24. Hsieh C.C., Chow K.C., Fahn H.J., et al. Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung. Ann Thoraic Surg. 66:1998;1159-1164.
25. Cox D.R. Regression models and life tables. J R Stat Assoc. 29:1972;187-220.
26. 2/E in the log rank test for survival data or incidence data. Biometrics. 29:1973;579-584.
27. Junginger T., Dutkowski P. Selective approach to the treatment of oesophageal cancer. Br J Surgery. 83:1996;1473-1477.
28. Ide H., Nakamura T., Hayashi K., et al. Esophageal squamous cell carcinoma: Pathology and prognosis. World J Surg. 18:1994;321-330.
29. Klimstra D.S. Pathologic prognostic factors in esophageal carcinoma. Semin Oncol. 121:1994;425-430.
30. Wang L.S., Huang M.S., Lin T.S., et al. A right thoracotomy approach with en bloc esophagectomy for carcinoma of intrathoracic esophagus - A preliminary report. J Surg Associ ROC. 24:1991;829-834.
31. Wang L.S., Lin H.Y., Chang C.J., et al. Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. J Surg Oncology. 67:1998;90-98.
32. Watson A. Operable esophaeal cancer: Current results from the West. World J Surg. 18:1994;361-366.
33. Zhang D.W., Cheng G.Y., Huang G.J., et al. Operable squamous esophageal cancer: Current results from the East. World J Surg. 18:1994;347-354.
34. Fok M., Law S.Y.K., Wong J. Operable esophageal carcinoma Current results from Hong Kong . World J Surg. 18:1994;355-360.
35. Muller J.M., Erasmi H., Stelzuer M., et al. Surgical therapy of esophageal carcinoma. Br J Surg. 77:1990;845-857.
36. Skinner D.B. Management of esophageal disease. 1988;736-763 W.B. Saunders, Philadelphia.
37. Akiyama H. Surgery for cancer of the esophagus. 1989;133 Williams and Wilkins, Baltimore.
38. Yoshider M., Iwatsuka M. Extended lymph node dissection for thoracic esophageal cancer. Disease of the esophagus. 1988;421-426 Springer-Verlag Company, New York.
39. Lieberman M.D., Shriver C.D., Bleckner S., et al. Carcinoma of the esophagus - Prognostic significance of histologic type. J Thorac Cardiovasc Surg. 109:1995;130-139.
40. Lu J.P., Xian M.S., Hayashi K. Morphologic features in esophageal squamous cell carcinoma of young adults in north China. Cancer. 74:1994;573-577.
41. Kuwano H., Watanabe M., Sadanaga N., et al. Univariate and multivariate analyses of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancer. J Surg Oncol. 57:1994;17-21.
42. Shimada Y., Imamura M. Prognostic significance of cell culture in carcinoma of the oesophagus. Br J Surg. 80:1993;605-607.
43. Sanjuan J.C.R., Bernal F.V., Garcia C.B., et al. Nuclear morphometry lacks prognostic value in squamous cell carcinoma of the oesophagus. Histol Histopath. 8:1993;505-508.
44. Giuli R., Sancho-Garnier H. Diagnostic, therapeutic and prognostic features of cancer of the esophagus: Results of the international prospective study conducted by the OESO group (790 patients). Surgery. 99:1986;614-622.
45. Hippelainen M., Eskelinen M., Lipponen P., et al. Mitotic activity index, volume corrected mitotic index and human papilloma-Virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Res. 13:1993;677-682.
46. Minu A.R., Endo M., Sunagawa M. Role of DNA ploidy patterns in esophageal squamous cell carcinoma - An ultraviolet microspectrophotometric study. Cancer. 74:1994;578-585.
47. Chanvitan A., Nekarda H., Casson A.G. Prognostic value of DNA index, S-phase fraction and p53 protein accumulation after surgical resection of esophageal squamous-cell carcinomas in Thailand. Int J Cancer. 63:1995;381-386.
48. Sasaki K., Murakami T.O., Murakami T.A., et al. Intratumoral heterogeneity in DNA ploidy of esophageal squamous cell carcinoma. Cancer. 68:1991;2403-2406.
49. Slamon D.J., Clark G.M., Wong S.G., et al. Human breast cancer: Correlation of relapse and survival with amplification of the erbB-2/neu oncogene. Science. 235:1987;177-182.
50. Ohashi K., Nemoto T., Eishi Y., et al. Proliferative activity and p53 protein accumulation correlate with early invasive trend, and correlates with differentiation grade in oesophageal squamous cell carcinomas. Virchows Arch. 430:1997;107-115.
51. Hardwick R.H., Barham C.P., Ozua P., et al. Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma: No correlation with prognosis. Eur J Surg Oncol. 23:1997;30-35.
52. Levine A.J., Perry M.E., Chang A., et al. The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer. 69:1994;409-416.
53. Coggi G., Bosari S., Roncalli M., et al. P53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer. 79:1997;425-432.
54. Bennett W.P., Hollstein M.C., Metcalf R.A., et al. P53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res. 52:1992;6092-6097.
55. Sarbia M., Porschen R., Borchard F., et al. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer. 74:1994;2218-2223.
56. Vijeyasingam R., Darnton S.J., Jenner K., et al. Expression of p53 protein in oesophageal carcinoma: Clinicopathological correlation and prognostic significance. Br J Surgery. 81:1994;1623-1626.
57. Prigent S.A., Lemoine N.R. The type I (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Res. 4:1992;1-24.
58. Sainsubry J.R., Farndon J.R., Needham G.K., et al. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1:1987;1398-1402.
59. Itakura Y., Sasano H., Shiga C., et al. Epidermal growth factor receptor overexpression in esophageal carcinoma: An immuno-histochemical study correlated with clinicopathologic finding and DNA amplification. Cancer. 74:1994;795-804.
60. Tsai C.M., Chang K.T., Wu L.H., et al. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutation, and cell proliferation characteristics in non-small cell lung cancer cell lines. Cancer Res. 56:1996;206-209.